Standard Family Office’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-68
Closed -$5K 132
2022
Q3
$5K Buy
+68
New +$5.76K ﹤0.01% 298
2021
Q3
Sell
-9,112
Closed -$973K 206
2021
Q2
$973K Hold
9,112
0.2% 48
2021
Q1
$819K Buy
9,112
+1,172
+15% +$110K 0.19% 43
2020
Q4
$734K Buy
+7,940
New +$709K 0.18% 46

Other funds holding DXCM

Standard Family Office's DXCM Position: Q4 2022 in Review

Standard Family Office sold out of DexCom (DXCM) in Q4 2022, closing a stake of 68 shares — an estimated $5K sold.

Standard Family Office first reported a position in DXCM in Q4 2020 and held it in 4 quarters. The position peaked at $973K in Q2 2021. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Standard Family Office reported no remaining DexCom position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 68 DexCom shares in Q4 2022, an estimated $5K.
  • Standard Family Office first reported a position in DexCom in Q4 2020 and held it in 4 quarters.
  • Standard Family Office's DexCom position peaked at $973K in Q2 2021.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.